Among ccRCC cohorts with clinical outcome information, SSA4 functioned as a risk factor; based on median expression, we found that the high SAA4 expression subgroup displayed shorter survival than the low subgroup (Figure 10(d)). The gene discussed is SAA4; the disease is nonpapillary renal cell carcinoma.